These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34547375)

  • 1. New concepts on immunology of Multiple Sclerosis.
    Couloume L; Michel L
    Presse Med; 2021 Jun; 50(2):104072. PubMed ID: 34547375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in Multiple Sclerosis Research: An Example of Bedside to Bench.
    Hauser SL
    JAMA; 2020 Sep; 324(9):841-842. PubMed ID: 32379266
    [No Abstract]   [Full Text] [Related]  

  • 3. Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis.
    Mestre L; Carrillo-Salinas FJ; Mecha M; Feliú A; Espejo C; Álvarez-Cermeño JC; Villar LM; Guaza C
    Front Immunol; 2019; 10():1374. PubMed ID: 31258540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota-dependent CCR9+CD4+ T cells are altered in secondary progressive multiple sclerosis.
    Kadowaki A; Saga R; Lin Y; Sato W; Yamamura T
    Brain; 2019 Apr; 142(4):916-931. PubMed ID: 30770703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the innate and adaptive immune responses in the course of multiple sclerosis.
    Hemmer B; Kerschensteiner M; Korn T
    Lancet Neurol; 2015 Apr; 14(4):406-19. PubMed ID: 25792099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis.
    Lassmann H
    Front Immunol; 2018; 9():3116. PubMed ID: 30687321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances.
    Bar-Or A; Li R
    Lancet Neurol; 2021 Jun; 20(6):470-483. PubMed ID: 33930317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets.
    Holmøy T
    Minerva Med; 2008 Apr; 99(2):119-40. PubMed ID: 18431322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions.
    Fransen NL; Hsiao CC; van der Poel M; Engelenburg HJ; Verdaasdonk K; Vincenten MCJ; Remmerswaal EBM; Kuhlmann T; Mason MRJ; Hamann J; Smolders J; Huitinga I
    Brain; 2020 Jun; 143(6):1714-1730. PubMed ID: 32400866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.
    Jilek S; Schluep M; Meylan P; Vingerhoets F; Guignard L; Monney A; Kleeberg J; Le Goff G; Pantaleo G; Du Pasquier RA
    Brain; 2008 Jul; 131(Pt 7):1712-21. PubMed ID: 18550621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perturbed Microbiota/Immune Homeostasis in Multiple Sclerosis.
    Sterlin D; Larsen M; Fadlallah J; Parizot C; Vignes M; Autaa G; Dorgham K; Juste C; Lepage P; Aboab J; Vicart S; Maillart E; Gout O; Lubetzki C; Deschamps R; Papeix C; Gorochov G
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(4):. PubMed ID: 33975914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating CD8+CD56-perforin+ T cells are increased in multiple sclerosis patients.
    Giovanni F; Domenico P; Alessandro M; Raffaele I; Viviana N; Katia PA; Paola BA
    J Neuroimmunol; 2011 Dec; 240-241():137-41. PubMed ID: 22001684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological differences between classical phenothypes of multiple sclerosis.
    Iwanowski P; Losy J
    J Neurol Sci; 2015 Feb; 349(1-2):10-4. PubMed ID: 25586536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A minimal unified model of disease trajectories captures hallmarks of multiple sclerosis.
    Kannan V; Kiani NA; Piehl F; Tegner J
    Math Biosci; 2017 Jul; 289():1-8. PubMed ID: 28365299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis: oligoclonal bands still yield clues about multiple sclerosis.
    Cross AH; Wu GF
    Nat Rev Neurol; 2010 Nov; 6(11):588-9. PubMed ID: 21048798
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytokine producing CD8+ T cells are correlated to MRI features of tissue destruction in MS.
    Killestein J; Eikelenboom MJ; Izeboud T; Kalkers NF; Adèr HJ; Barkhof F; Van Lier RA; Uitdehaag BM; Polman CH
    J Neuroimmunol; 2003 Sep; 142(1-2):141-8. PubMed ID: 14512173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease.
    Killestein J; Den Drijver BF; Van der Graaff WL; Uitdehaag BM; Polman CH; Van Lier RA
    Mult Scler; 2001 Jun; 7(3):145-50. PubMed ID: 11475436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Approach to Discriminate Subgroups in Multiple Sclerosis.
    Farrokhi M; Saadatpour Z; Fadaee E; Saadatpour L; Rezaei A; Moeini P; Amani Beni A
    Iran J Allergy Asthma Immunol; 2016 Dec; 15(6):536-546. PubMed ID: 28129686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased CD8+ central memory T cells in patients with multiple sclerosis.
    Liu GZ; Fang LB; Hjelmström P; Gao XG
    Mult Scler; 2007 Mar; 13(2):149-55. PubMed ID: 17439879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple Sclerosis: Mechanisms and Immunotherapy.
    Baecher-Allan C; Kaskow BJ; Weiner HL
    Neuron; 2018 Feb; 97(4):742-768. PubMed ID: 29470968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.